Related by context. All words. (Click for frequent words.) 78 PDUFA Prescription Drug 64 Act PDUFA date 63 Drug User Fee 63 FDAAA 63 PDUFA 63 Act PDUFA 60 MDUFMA 60 FDA Modernization Act 60 Subpart E 59 ISO Vorin TM 59 Premarket Approval 59 Drug Administration Amendments 58 PDUFA Date 58 Expedited Review 58 Devices Advisory Panel 58 BRILINTA 58 injectable formulations 58 liver resection surgeries 58 Prescription Drug User Fee 58 Accelerated Approval 57 postmarket surveillance 57 Subpart H 57 FDAs 56 Biologic License Application BLA 56 assigned PDUFA 56 Angiox ® 56 PDUFA date 56 postapproval 56 Pre IND 56 Generic Versions 56 Premarket Approval Application 56 ICH guidelines 56 FDA Advisory Panel 56 Use Authorization 55 authority Gurian Sherman 55 Biologics Licensing 55 OvaDx 55 Targretin capsules 55 Aloxi Injection 55 Approvable 55 cGMPs 55 Submits Supplemental 55 PLAVIX ® 55 granted Ortec 55 Cintredekin besudotox 55 Trobalt 55 Resubmission 55 Vimpat R 55 HepaGam B 55 Erythropoiesis Stimulating Agents ESAs 55 Pandemic Vaccine 55 postmarketing studies 54 eMDR 54 Files Investigational 54 Communications DDMAC 54 FDA Accepts 54 Drug Administration Modernization Act 54 UCB Keppra 54 HCl capsules 54 Product Monograph 54 BLAs 54 balsalazide tablet 54 eprodisate Fibrillex TM 54 Arzerra ofatumumab 54 Sanctura XR 54 Gamunex C 54 Combating Counterfeit Drugs 54 Helixate FS 54 MHLW 54 Morphine Sulfate 54 enoxaparin sodium injection 54 Somatuline R Autogel R 54 Stedesa 54 Submits NDA 54 dalbavancin 54 ANDA Filing 54 pregabalin Lyrica 54 Keppra XR 54 ICH E# 54 IND Investigational New 54 Submits Response 53 Genzyme Myozyme 53 darbepoetin alfa Aranesp 53 NASPER 53 IND Application 53 Risperidone Oral Solution 53 eCTD format 53 Receives Tentative FDA 53 Cand5 53 AstraZeneca Symbicort 53 EMBEDA ™ 53 NAMENDA 53 WHO prequalification 53 Somatuline Autogel 53 MIPPA 53 IND submission 53 SEASONIQUE 53 THALOMID 53 Mitigation Strategies REMS 53 Bazedoxifene 53 PMPRB 53 Zegerid OTC 53 Release Capsules 53 Seasonal Influenza Vaccine 53 OLEPTRO 53 clopidogrel bisulfate 53 Metozolv ODT 53 Use Authorization EUA 53 Danazol 53 NerPharMa 53 ULTRASE 53 Accelerated Assessment 53 MAA submission 53 TWYNSTA ® 53 Biologics Compendium 53 SEASONALE 53 gave Makena orphan 53 FDA Approvals 53 ENLIGHT 53 Postmarket 53 Amgen Nplate 53 Bioequivalence 53 lucinactant 53 FDA 53 Impax generic 53 CHMP recommendation 53 SmPC 52 Psoriasis Drug 52 Pivotal Clinical Trial 52 COLAZAL 52 nasal calcitonin product 52 R sipuleucel T 52 Nabi HB Intravenous 52 #CFR# 52 Announces Tentative Approval 52 XIAFLEX ™ 52 Adoxa 52 Focalin XR R 52 NCCN Drugs 52 NDA Submission 52 Biologic License Application 52 Cladribine 52 Endeavor Drug Eluting 52 ONGLYZA ™ 52 Montelukast 52 GRALISE 52 k Premarket Notification 52 Inhaled Insulin 52 ReFacto 52 Levothyroxine 52 Provenge prostate cancer 52 PrandiMet 52 METOZOLV ODT 52 Act FDAAA 52 Surfaxin lucinactant 52 highly purified pasteurized 52 Emezine 52 ACIP recommendations 52 Receives Approvable Letter 52 CryoSeal FS System 52 MoxDuo ® 52 Fast Track Status 52 Anthim 52 IDE Investigational Device Exemption 52 Generic Version 52 Vitrasert R 52 Research CDER 52 Files IND 52 PROVENGE ® 52 FDA Approvable Letter 52 Alvesco R 52 MelaFind R 52 Brinavess 52 SYCREST 52 Marketing Authorisation 52 Tamoxifen Citrate 52 indiplon capsules 52 Kombiglyze XR 51 Fortical R 51 Zenpep 51 Aplenzin ™ 51 Eli Lilly Cymbalta 51 Vectibix panitumumab 51 Febuxostat 51 Carbidopa Levodopa 51 seroquel quetiapine 51 Plenaxis TM 51 REMINYL ® 51 Revo MRI 51 Project BioShield Act 51 Somatuline Depot 51 Fortovase 51 Sanvar R 51 TYGACIL 51 pulls Darvon painkiller 51 varenicline tartrate 51 propoxyphene containing 51 CERVARIX R 51 Neuromodulation System 51 reapproval 51 Gestiva TM 51 Bayer Xarelto 51 Dalbavancin 51 Zolpimist 51 DORIBAX 51 Retacrit 51 NCCN Clinical Practice Guidelines 51 BeneFIX 51 Wellbutrin XL R 51 PMA Supplement 51 IV acetaminophen 51 application sNDA 51 HCPCS code 51 Kynapid 51 CigRx TM 51 PMA submission 51 Frova ® 51 ARIXTRA R 51 radioimmunotherapeutic agent 51 Drug Administration FDA 51 Noxafil 51 Patanase 51 Application BLA 51 RANK Ligand inhibitor 51 PROTONIX 51 ALGRX 51 premarket notification 51 Cancidas 51 Orapred ODT 51 REMICADE infliximab 51 sNDA submission 51 generic biologic 51 buccal tablets 51 CLIA waiver 51 Fast Track designations 51 sublingual tablets 51 SPARLON 51 Metformin Hydrochloride 51 Quadrivalent 51 GLP1 agonist 51 CIP TRAMADOL ER 51 ZEGERID Capsules 51 Arranon 51 Glucomed 51 Synerx 51 CDER 51 ENTEREG ® 51 Xolegel 51 Angiomax bivalirudin 51 mesylate tablets approved 51 Hiberix 51 CLIA waived status 51 Acurox r Tablets 51 ARCOXIA 51 vapreotide acetate 51 Marketing Authorisation Application MAA 51 postmarket safety 51 Xifaxan rifaximin 51 Granted Orphan Drug 51 pediatric exclusivity 51 LUVOX CR 51 Civacir 51 Expanded Indication 51 tramiprosate ALZHEMED TM 51 Physician Payment 51 PREVU x LT 51 Vertex hepatitis C 51 Ramelteon 50 successfully commercialize Iluvien 50 ACUROX ® 50 Valtropin 50 Drug Administration www.fda.gov 50 markets HP Acthar 50 extralabel 50 Posaconazole 50 Propoxyphene 50 Anidulafungin 50 rotavirus vaccine Rotarix 50 Pharmacopeial Convention 50 Phase III Clinical Trial 50 Pediatric Exclusivity 50 Modernization Act MMA 50 Cefazolin 50 Calcium Acetate 50 Nonprescription Drug Consumer 50 oxymorphone ER 50 Esbriet pirfenidone 50 anagrelide 50 capsules USP 50 Cethromycin 50 ZEGERID Chewable Tablets 50 Dexilant 50 Submits Biologics License Application 50 sNDA filing 50 metoprolol succinate 50 Captisol enabled 50 Voraxaze 50 EXALGO 50 levalbuterol 50 Emezine R 50 INTUNIV TM guanfacine extended 50 Octreotide 50 ANVISA 50 Improvement Amendments 50 Genzyme Synvisc 50 fluvoxamine maleate 50 GPhA 50 FMIA 50 MelaFind ® 50 IXIARO ® 50 pixantrone NDA 50 AdreView 50 Toremifene 50 OsmoPrep 50 Diastat 50 Lilly Evista 50 MVax 50 Pazopanib 50 ANDA filings 50 Biosimilars 50 supplemental biologics 50 casopitant 50 CONBRIZA 50 Auxilium Pharma 50 PD2i Analyzer TM 50 System HCPCS 50 Homeopathic Pharmacopoeia 50 BioSante Pharmaceuticals Announces 50 Liprotamase 50 Children VFC 50 SPRIX ® 50 Raptiva efalizumab 50 requiring Asthmatx 50 guanfacine extended release 50 Lilly Cymbalta 50 Metoprolol Succinate 50 containing LABAs 50 BLA filing 50 Irinotecan Hydrochloride Injection 50 Zidovudine Tablets 50 PrandiMet TM 50 Humira adalimumab 50 Drug Submission 50 Enjuvia 50 Fluticasone Propionate Nasal Spray 50 Velcade bortezomib 50 Loxapine 50 FDA Approves Expanded 50 FDA approvable letter 50 Genetic Therapies Directorate 50 ProUroScan 50 CREON R 50 autologous cellular immunotherapy 50 Treat Anemia 50 Betaseron ® 50 ORENCIA ® 50 Product Designation 50 Drug Application 50 divalproex sodium 50 Nonprescription 50 OraTest 50 Onrigin 50 Directorate TPD 50 Supplemental Biologics License Application 50 PD2i Cardiac Analyzer 50 Lauriad ® 50 novel oral anticoagulant 50 OTC Zegerid 50 Keppra ® levetiracetam 49 INVEGA SUSTENNA 49 Lipofen 49 BiDil XR 49 bioequivalency 49 IU vial 49 Maleate 49 Nascobal 49 DNAwithPap TM Test 49 Terbinafine 49 Preotact 49 GRAS determination 49 DPCO 49 orally disintegrating 49 Prevacid #HR 49 BLA submission 49 Certican 49 DrugAdministration 49 Exelbine NDA 49 NUEDEXTA ™ 49 Generic Version Of 49 Oracea ® 49 RECOTHROM R 49 Methylin 49 Stavzor 49 Issues Complete Response 49 Egrifta 49 Velaglucerase Alfa 49 Sprycel dasatinib 49 NeutroSpec 49 ANDA applicant 49 Sanofi Acomplia 49 hoFH 49 Orphan Status 49 Abstral ® 49 Afluria 49 Grants Orphan Drug 49 PDUFA reauthorization 49 Orphan Designation 49 BioGlue R 49 RIGScan CR 49 Reauthorize 49 single injection viscosupplement 49 SWHCS 49 Neovasc Reducer 49 Q#IR 49 Wyeth Progenics 49 Premarket Notification 49 Lamictal ODT 49 Bifeprunox 49 Conditional Approval 49 RX ACCULINK 49 octreotide acetate 49 Receives Orphan Drug Designation 49 balsalazide 49 Aplenzin 49 quetiapine fumarate 49 Increlex TM 49 Multiple Ascending Dose 49 AstraZeneca Iressa 49 reslizumab 49 Triage Stroke Panel 49 Mylan Receives Approval 49 Firazyr 49 Intermezzo ® NDA 49 rilonacept 49 Oral Solution 49 QNEXA 49 Pentavalent 49 Tarceva TM 49 CIP Fenofibrate 49 Ropinirole 49 Standards CFATS 49 Dabigatran etexilate 49 Labeling SPL 49 asymptomatic hyperuricemia 49 Proquin 49 trivalent inactivated influenza 49 Gestiva ™ 49 Plenaxis R 49 Combunox 49 HR.# 49 Angiox 49 Humenza 49 Losartan Potassium 49 OTC ZEGERID 49 Hatch Waxman 49 Fluconazole 49 Somatuline R Depot 49 SPL# Gel vaginal microbicide 49 Marketing Authorisation Application 49 Rasilez HCT 49 Product Characteristics 49 FFDCA 49 ImClone Erbitux 49 Xibrom QD 49 Cerenia 49 Ixempra 49 Receives Approval From 49 National Coverage Determination 49 Clinical Trial Evaluating 49 Shire BioChem Inc. 49 Food Allergen Labeling 49 Liberte TM 49 Receives Tentative Approval 49 Cetirizine Hydrochloride Syrup 49 Submits Investigational 49 Drug Administration Oncologic Drugs 49 Riluzole 49 Orexigen Contrave 49 IMVAMUNE 49 Stronger Warnings 49 MyVax 49 PRISTIQ 49 NDA resubmission 49 Linjeta 49 FACTIVE R gemifloxacin 49 Amrix 49 Ventavis ® 49 Mutual Recognition Procedure 49 Sanofi Aventis Allegra 49 Centralized Procedure 49 capsule formulation 49 onabotulinumtoxinA 49 Committee IACUC 49 BioDelivery Sciences 49 SANVAR 49 SURFAXIN 49 FDAâ € ™ 49 Luveris 49 enoxaparin Lovenox 48 LEVADEX ™ 48 TKM Ebola 48 Alair System 48 Prostate Cancer Vaccine 48 Imvamune 48 EDQM 48 Begin Clinical Trials 48 FACTIVE tablets 48 Potiga 48 Receives Complete Response 48 Elestrin TM 48 Dendreon Provenge 48 dispensed prescriptions 48 Swissmedic 48 spokeswoman Lenore Gelb 48 opioid narcotic 48 generic Lipitor 48 rejected Merck Arcoxia 48 Viviant 48 Obtains CE Mark 48 Arzerra TM 48 Nebido 48 donepezil hydrochloride 48 exenatide Byetta 48 Argatroban 48 Raptiva R 48 Celebrex celecoxib 48 DYSPORT TM 48 Abuse Prevention Act 48 Pentacel vaccine 48 Troxatyl TM 48 LIALDA 48 Xyrem ® 48 please visit www.middlebrookpharma.com 48 Receives CE Marking 48 NEBIDO 48 CIP ISOTRETINOIN 48 Kaletra tablet 48 Zemplar 48 OraQuick test 48 Pixuvri 48 Gadavist 48 allergen labeling 48 serotonin norepinephrine reuptake inhibitor 48 Emend 48 Intuniv 48 APRISO 48 Doxycycline Tablets 48 Daytrana ™ 48 FDA Endocrinologic 48 DEXILANT 48 Milestone Payment From 48 HPV vaccine GlaxoSmithKline Cervarix 48 Gonal f 48 INVEGA ™ 48 RiskMAP 48 intra nasal 48 Biological License Application 48 Rotarix ® 48 Filgrastim 48 Moxatag 48 Biologics License Application BLA 48 milligram capsule 48 Safe Cosmetics Act 48 Barr ANDA 48 Oncologic Drugs Advisory 48 teratogenicity 48 MMSEA 48 Visit www.fda.gov medwatch 48 DMEPOS supplier 48 Priority Review 48 Prepandrix 48 Decentralized Procedure 48 Pfizer inhaled insulin 48 vaccine RotaTeq 48 Amlodipine Besylate Tablets 48 Reauthorizing 48 Pirfenidone 48 Inovocox TM 48 ATD TM gel 48 Orphan Drugs 48 Focalin XR 48 SUMAVEL 48 Somatropin 48 Idenix Novartis 48 AIDAC 48 painkiller Actiq 48 Serious Side Effects 48 Natroba 48 Investigational Device Exemption 48 Raptiva ® 48 Augment ™ 48 glucophage metformin 48 temporarily wheezing shortness 48 Medicare Physician Fee 48 FDA Circulatory System 48 INVEGA ® 48 MEVACOR 48 prescribe Seroquel 48 Amgen Prolia 48 Orphan designation 48 approvable letters 48 VALSTAR 48 oxycodone HCl 48 Aivlosin 48 Soriatane 48 Icatibant 48 Pfizer maraviroc 48 nonsedating antihistamine 48 Hospital Outpatient Prospective 48 Dr. Gulfo 48 Rapaflo 48 Program PDMP 48 Muraglitazar 48 equivalent Reglan 48 sitaxsentan sodium 48 ISO Vorin 48 TNF blocker 48 Drug Fails 48 #L Sterilizer 48 Teva ANDA 48 unapproved colchicine 48 Velac 48 Nuedexta 48 Zelapar 48 Practice Guideline 48 Melody Transcatheter Pulmonary Valve 48 NOXAFIL 48 postmarket studies 48 transdermal estradiol 48 Tamsulosin capsules 48 Market Approval PMA 48 Merck Januvia 48 Kiacta 48 Clindesse TM 48 AstraZeneca Toprol 48 ATryn ® 48 Citizen Petition 48 Increlex R 48 Prodarsan 48 AstraZeneca Brilinta 48 Gabapentin Tablets 48 Gestiva 48 FDA Okays 48 nitrofurantoin 48 PRIALT 48 FDA Orphan Drug 48 rThrombin 48 Zebinix R 48 Levothyroxine Sodium 48 Evoltra 48 ANDAs pending 48 opiate analgesic 48 IND Filing 48 Dementia Related Psychosis 48 Taro Receives 48 Metabolic Drugs 48 GTC recombinant human 48 5 lipoxygenase inhibitor 48 Foradil Aerolizer 48 Salix Pharma 48 Tilidine 48 DORYX 48 Glaxo Cervarix 48 RevAssist 48 Onsolis 47 Metformin HCl 47 Fentanyl TAIFUN R 47 cefuroxime axetil 47 multidose 47 Meets Primary Endpoint 47 intravenous acetaminophen 47 Electronic Submission 47 Ranolazine 47 #k Clearance 47 Act PDUFA guidelines 47 Levonorgestrel 47 Savella TM 47 postmarketing surveillance 47 Fast Tracked 47 Receives Positive Opinion 47 ADVANCE PD 47 Drug Administration FDA Oncologic 47 treat atrial flutter 47 Dostinex 47 successfully commercialize Silenor 47 Medicaid Extenders 47 Drug Administration 47 fusion enhancers 47 FDA Anti Infective 47 Nivestim 47 Wellbutrin XL ® 47 ezogabine 47 submit Biologics License 47 fentanyl transdermal system 47 Psychopharmacologic Drugs Advisory 47 Forsteo 47 Complete Response 47 moxidectin 47 License Application 47 Pfizer Aricept 47 generic Prilosec 47 PROMACTA CARES 47 Pivotal Study 47 OVIDE 47 CLIA Waiver 47 PIX# trial 47 Metformin GR 47 inhibit platelet function 47 supplemental Biologics License Application 47 Phospha E R 47 Needlestick Safety 47 OMP designation 47 Vpriv 47 buccal tablet 47 Serdolect ® 47 approvability 47 Nascobal Nasal Spray 47 REMS 47 infant formula contaminant 47 T Pred 47 Marketing Authorization 47 MK #B 47 Phase 1b Clinical Trial 47 Tentative Approval 47 Premarket Approval PMA 47 Amgen Vectibix 47 Nasdaq SPPI 47 Zavesca 47 ENRICH trial 47 Periostat 47 Acthar Gel 47 Program Reauthorization Act 47 Doribax 47 Promist 47 Drug Approvals 47 AZILECT ® 47 Frova R 47 hylan GF 47 Drug Administration KFDA 47 Zarnestra 47 biogeneric drugs 47 Poisons Schedule Committee 47 BioDelivery 47 ixabepilone 47 Omacor ® 47 Testosterone Patch 47 ANDA abbreviated 47 RIGScan ™ 47 Econiche 47 Kerastick 47 nanofiltered plasma derived 47 Remicade infliximab 47 Physician Payments 47 solifenacin succinate 47 paliperidone palmitate 47 Solzira 47 Complies 47 ADCIRCA 47 AneuRx 47 Physician Payments Sunshine 47 Neupro R 47 Thalidomide Pharmion 47 Program NCEP 47 Staph aureus infections 47 PMAs 47 Gynazole 1 47 NitroMist TM 47 Reduces Mortality 47 FIRMAGON R 47 Adverse Event 47 Tredaptive 47 Drug Eluting Stent System 47 Taxol r 47 orphan medicinal 47 Alferon N Injection 47 Focetria 47 OPANA ER 47 Alexion Soliris 47 Tasigna nilotinib 47 License Application sBLA 47 besifloxacin 47 Hatch Waxman Act 47 Glycopyrrolate 47 Lupus Drug 47 TIGRIS R 47 Patient Enrollment 47 BioThrax ® 47 Tekturna Rasilez 47 Sonolith i move 47 Sycrest 47 Videx EC 47 paliperidone ER 47 Cheaper Medicines Bill 47 Medidur TM FA 47 zolpidem tartrate sublingual tablet 47 methylphenidate HCl 47 conjugated estrogens 47 Animal Efficacy 47 Avoid jalapenos 47 KAPVAY ™ 47 Oracea R 47 Receives Fast Track 47 FDA Psychopharmacologic Drugs 47 Yondelis ® 47 overthe counter 47 Edarbi 47 Lyrica pregabalin 47 www.soliris.net 47 Genetically Modified Salmon 47 Patient Self Determination 47 Exenatide LAR 47 Lumacan 47 PREVU x POC 47 Association IDMA 47 OTC monograph 47 isosorbide mononitrate 47 PROCAPS 47 Pharmacopeia USP 47 Neurological Devices 47 telavancin NDA 47 enoxaparin sodium 47 Thelin TM 47 Absorbable 47 Prescription Drug Benefit 47 Novartis AG Galvus 47 ANTEGREN 47 NMEs 47 JJDPA 47 GRAS affirmation 47 Fluviral 47 ColonSentry test 47 F.D.A. 47 Genentech Provides Update 47 Bayer Yasmin 47 ISTODAX 47 FDA Complete Response 47 Intravenous Formulation 47 GHTF 47 Adjuvant Treatment 47 ANDAs abbreviated 47 lipoglycopeptide 47 Phenergan labeling 47 FDA Dermatologic 47 bioequivalent versions 47 Mucotrol 47 risedronate sodium tablets 47 timolol maleate 47 nontherapeutic 47 Phase III Trial 47 sucralfate 47 Tekturna HCT ® 47 Pennsaid R 47 Frovatriptan 47 Gralise 47 levocetirizine 47 Cinacalcet HCl 47 FOSAMAX PLUS D 47 vitro dissolution 47 received CE Conformite 47 Establishment Inspection 47 ELIQUIS 47 oral hypoglycemic 47 GRAS notification 46 easypod R 46 Pliaglis 46 Shire Adderall XR 46 development DSC# novel 46 Purepac 46 orphan designation 46 Prexige lumiracoxib 46 Nasdaq OSCI 46 Amylin Byetta 46 Weight Loss Drug 46 Cumulase 46 Approvable letter 46 ticagrelor Brilinta 46 designated Restanza 46 OFPA 46 Rhucin R 46 PROVIGIL 46 Livalo 46 Epilepsy Drug 46 commercialize toremifene 46 ibuprofen Injection 46 Pulminiq 46 oral rivaroxaban 46 Treximet 46 Act DSHEA 46 lorcaserin NDA 46 UVIDEM 46 thalidomide Thalomid 46 Lorqess 46 Exalgo 46 Simvastatin Tablets 46 EGRIFTA 46 DrugAdministration FDA 46 alvimopan 46 Rhucin ® 46 Cipralex ® 46 Drug Adminstration 46 Sublicense 46 UCB Cimzia 46 Hatch Waxman Amendments 46 ADVERSE EVENTS 46 IMPELLA R 46 SOLODYN 46 approved incretin mimetic 46 Exemption IDE approval 46 Marketing Authorization Applications 46 drug belatacept 46 SCHWARZ PHARMA 46 sNDAs 46 Tramadol ER 46 Sumatriptan Succinate 46 Pivotal Phase II 46 BEMA Granisetron 46 Removab 46 Rapinyl 46 Hydrocodone Bitartrate 46 revaccinate according 46 Voluntary Withdrawal 46 Alogliptin 46 Approval Process 46 Besivance 46 Ceftobiprole 46 Cervical Cancer Vaccine 46 Zemplar Capsules 46 intravenous iclaprim 46 Research CBER 46 Valtrex valacyclovir 46 GTC recombinant form 46 Fampridine SR NDA 46 Abilify aripiprazole 46 Inc. NASDAQ NEOL 46 blood thinner Xarelto 46 Darvocet Darvon 46 Telavancin 46 Pharmacopeial USP Convention 46 Sensipar 46 levoleucovorin 46 Caduet 46 TORISEL TM 46 ruxolitinib 46 PROGENSA R 46 Orthopedic Advisory Panel 46 vaccine Synflorix 46 Esbriet ® 46 ENJUVIA 46 Registration Evaluation Authorization 46 Blood Pressure Drug 46 PhosLo 46 Hematide ™ peginesatide 46 cephalexin keflex keftabs biocef 46 SynCon 46 gluteal injection 46 Azathioprine 46 Regains NASDAQ 46 ZEGERID Powder 46 Neurodex 46 Zytiga 46 Evamist TM 46 Paragraph IV certifications 46 Reimportation 46 Infusion System 46 Zyflo CR 46 Biogen Elan 46 recombinant biopharmaceutical 46 multiple dose vials 46 Mitigation Strategy 46 Vilazodone 46 Intelence 46 Onconase 46 Regulatory Filing 46 MethyPatch 46 Pivotal Phase III 46 anagrelide hydrochloride 46 Health HITECH Act 46 Teysuno 46 Prescribing Information 46 transdermal estrogen therapy 46 Telzir 46 Meridia sibutramine 46 Entereg alvimopan 46 Teflaro 46 levetiracetam Keppra 46 Oxymorphone 46 Resubmits 46 Exforge HCT 46 PL #-# [001] 46 Gladys Mensing took 46 XIBROM 46 FIRAZYR 46 Administration TGA 46 S. #/HR [002] 46 fluoroquinolone antibiotic 46 Novartis Galvus 46 Keppra XR TM 46 Lofexidine 46 Adhesion Barrier